Skip to content
Menu

IRADIMED CORPORATION IRMD

Full chart Compare
Set alert

Price alert · IRMD

All alert types
81.26 USD -1.05 (-1.28%)

Regular-session close

81.26 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

80.67 Day range 82.94
76.35 52-week range 107.90
YTD
-16.47%
1 year
-6.16%

5D -1.19 (-1.38%)

8688MonTueWedThuFri85.35
Market cap
1.04B
Revenue (ttm)
89.34M
Profit margin
26.85%
EPS (ttm)
1.87
Shares out
12.79M
P/E ratio
43.45
Forward P/E
33.35
Dividend
0.80 (0.97%)
Ex-dividend date
Nov 13, 2026
YTD return
-16.47%
1-year return
-6.16%
Volume
109.92K
Avg volume
120.03K
Open
81.40
Previous close
82.31
Day's range
80.67 – 82.94
52-week range
76.35 – 107.90
Beta
0.94
Price target
118.00 (+45.2%)
Earnings date
Feb 9, 2027
50-day average
85.28
200-day average
91.52

Key statistics

Enterprise value
989.30M
Price / sales
11.63
Price / book
9.76
Payout ratio
41.18%
Revenue growth
14.20%
Free cash flow
17.53M
Total cash
63.29M
Return on equity
23.42%
Short % of float
7.12%

Fundamental scorecard

20 of 25 checks passed on IRMD’s reported financials

ValueGrowthProfitabilityHealthDividend

20of 25 checks passed

  • Value 0 of 5
  • Growth 5 of 5
  • Profitability 5 of 5
  • Financial health 5 of 5
  • Dividend 5 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
IRMD Revenue — quarterly 24.20M
IRMD Net income — quarterly 6.51M
IRMD EPS — quarterly 0.51

Earnings

IRMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 9, 2027Dec 30, 20260.55———
Oct 30, 2026Sep 30, 20260.550.550.000.00%
Jul 31, 2026Jun 30, 20260.440.46+0.02+4.55%
May 1, 2026Mar 31, 20260.450.49+0.04+8.89%
Feb 10, 2026Dec 31, 20250.490.54+0.05+10.20%
Nov 3, 2025Sep 30, 20250.480.47-0.01-2.08%

Upgrades / downgrades

IRMD analyst upgrades and downgrades
DateFirmActionFromTo
Sep 22, 2026Needhaminit—Hold
Apr 2, 2026Freedom Brokerinit—Buy
Feb 14, 2025Roth MKMreitBuyBuy
Aug 2, 2024Roth MKMmainBuyBuy
Aug 2, 2021Roth Capitalmain—Buy
Jul 31, 2017Roth CapitalupNeutralBuy

About IRADIMED CORPORATION

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
iradimed.com

News

Your note

Sign in to keep a note on IRMD — it syncs with the Stock Master app.

Insider holders

IRMD insider holders
InsiderRelationLatest transactionDateShares held
ALLEN MONTY KDirectorSaleSep 2, 202619,581
CHIPRIN JEFFOfficerConversion of Exercise of derivative securityDec 10, 2025687
GLENN JOHN FChief Financial OfficerConversion of Exercise of derivative securityJun 17, 202611,937
HAWKINS JAMES BDirectorConversion of Exercise of derivative securityDec 10, 202529,647
SCHAREN-GUIVEL HILDA FREDERIQUEDirectorSaleJun 3, 20265,598
SUSI ROGER EChief Executive OfficerSaleMay 31, 20260

Institution ownership

IRMD institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.50%958,67177.90MSep 29, 2026
Copeland Capital Management, LLC2.99%382,01331.04MSep 29, 2026
Vanguard Capital Management LLC2.88%368,39529.94MSep 29, 2026
Kayne Anderson Rudnick Investment Management LLC2.77%354,04028.77MSep 29, 2026
Renaissance Technologies, LLC2.74%350,61228.49MSep 29, 2026
Geode Capital Management, LLC2.32%296,22724.07MSep 29, 2026

Fund ownership

IRMD fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.07%264,36621.48MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.65%211,26917.17MSep 29, 2026
Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund1.07%136,77211.11MJun 29, 2026
T. Rowe Price Small-Cap Value Fund, Inc.0.91%116,9029.50MJun 29, 2026
JNL Series Trust-JNL Multi-Manager Small Cap Growth Fund0.80%102,5708.33MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.72%92,5677.52MAug 30, 2026